We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current CYTO market cap is 503.28k. The company's latest EPS is CHF -75.9027 and P/E is -0.04.
Quarter End | Mar 2014 | ||||
---|---|---|---|---|---|
CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
Total Revenue | 0 | ||||
Operating Income | -5.86M | ||||
Net Income | -5.86M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
Total Revenue | 0 | 0 | 0 | 64k | 306k |
Operating Income | -11.47M | -7.26M | -5.5M | -17.1M | -26.13M |
Net Income | -11.5M | -6.63M | -8.2M | -17.39M | -26.53M |
Quarter End | Mar 2014 | ||||
---|---|---|---|---|---|
CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
Total Assets | 20.86M | ||||
Total Liabilities | 3.99M | ||||
Total Equity | 16.88M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
Total Assets | 9.88M | 9.23M | 20.8M | 18.84M | 6.3M |
Total Liabilities | 6.23M | 3.19M | 4.03M | 6.13M | 14.62M |
Total Equity | 3.65M | 6.04M | 16.77M | 12.71M | -8.32M |
Quarter End | Mar 2014 | ||||
---|---|---|---|---|---|
CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
Operating | -5.19M | ||||
Investing | -57k | ||||
Financing | -87k |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
Operating | -13.23M | -8.39M | -4.84M | -13.67M | -8.68M |
Investing | -1.82M | -3M | -2.32M | -3.51M | -2.14M |
Financing | 5.73M | 7.38M | 16.96M | 6.61M | 9.83M |
Market Cap | 503.28k |
Price to Earnings Ratio | -0.04 |
Price to Sales Ratio | 3.47 |
Price to Cash Ratio | 70.86 |
Price to Book Ratio | -0.13 |
Dividend Yield | - |
Shares Outstanding | 349.5k |
Average Volume (1 week) | 65.89k |
Average Volume (1 Month) | 3.48M |
52 Week Change | -93.68% |
52 Week High | 28.40 |
52 Week Low | 1.405 |
Spread (Intraday) | 0.04 (2.7%) |
Company Name | Altamira Therapeutics Ltd |
Address |
dornacherstrasse 210 basel 4053 |
Website | https://altamiratherapeutics.com |
Industry | med, dental, hosp eq-whsl (5047) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions